Доступ предоставлен для: Guest
Critical Reviews™ in Oncogenesis
Главный редактор: Benjamin Bonavida (open in a new tab)

Выходит 4 номеров в год

ISSN Печать: 0893-9675

ISSN Онлайн: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Genetic Alterations in Liver Carcinogenesis: Implications for New Preventive and Therapeutic Strategies

Том 11, Выпуск 1, 2000, 44 pages
DOI: 10.1615/CritRevOncog.v11.i1.20
Get accessGet access

Краткое описание

In this review, genetic changes known to occur in human and experimental animal hepatocarcinogenesis are evaluated comparatively, with the aim of identifying genes that could potentially be targets of new preventive and therapeutic strategies, albeit the fact that although a step-by-step analysis of the pre-malignant stages has been largely accomplished in experimental hepatocarcinogenesis, this goal is still elusive in the case of humans. Overexpression of several of the genes implicated in the MARK signaling cascade and cell cycle control appears to be most likely responsible for initiated cells acquiring a proliferating phenotype that facilitates the accumulation of structural changes in additional genes, resulting in the generation of autonomously growing preneoplastic and neoplastic lesions. Several gene abnormalities seen in precancerous lesions of rodents also occur in human hepatocellular carcinomas, suggesting that at least some of them could be present also in human precancerous lesions. Furthermore, there are reports that epigenetic events, such as abnormal DNA methylation, may be critical in hepatocarcinogenesis. DNA hypomethylation is an early event, both in human and experimental hepatocarcinogenesis, and its role in the activation of various genes, has been postulated. In recent years, linkage analysis studies have led to the identification of susceptibility/resistance loci that influence the progression stage of hepatocarcinogenesis in mice and rats. The relevance of these findings, though, will depend on the identification of the genes, and on whether in humans there are genes ortholog with rodent's susceptibility/ resistance genes. It is proposed that rodent hepatocarcinogenesis represents a promising model for the identification of genes implicated in the early stages of the process, and that many of these genes may represent key targets for the application of gene therapy in the prevention and treatment of liver cancer.

ЦИТИРОВАНО В
  1. Sagmeister Sandra, Drucker Claudia, Losert Annemarie, Grusch Michael, Daryabeigi Anahita, Parzefall Wolfram, Rohr-Udilova Nataliya, Bichler Christoph, Smedsrød Bård, Kandioler Daniela, Grünberger Thomas, Wrba Fritz, Schulte-Hermann Rolf, Grasl-Kraupp Bettina, HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis, Journal of Hepatology, 49, 6, 2008. Crossref

  2. Psyrri Amanda, Arkadopoulos Nikolaos, Vassilakopoulou Maria, Smyrniotis Vassilios, Dimitriadis George, Pathways and targets in hepatocellular carcinoma, Expert Review of Anticancer Therapy, 12, 10, 2012. Crossref

  3. De Miglio Maria R., Pascale Rosa M., Simile Maria M., Muroni Maria R., Virdis Patrizia, Kwong Kelvin M.-T., Wong Leslie K.L., Bosinco Giovanni M., Pulina Franca R., Calvisi Diego F., Frau Maddalena, Wood Geoffrey A., Archer Michael C., Feo Francesco, Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats, International Journal of Cancer, 111, 1, 2004. Crossref

  4. Laurent–Puig Pierre, Legoix Patricia, Bluteau Olivier, Belghiti Jacques, Franco Dominique, Binot Frederic, Monges Geneviève, Thomas Gilles, Bioulac–Sage Paulette, Zucman–Rossi Jessica, Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis, Gastroenterology, 120, 7, 2001. Crossref

  5. Sindhu Edakkadath R., Firdous Alikkunjhi P., Ramnath Viswanathan, Kuttan Ramadasan, Effect of carotenoid lutein on N-nitrosodiethylamine-induced hepatocellular carcinoma and its mechanism of action, European Journal of Cancer Prevention, 22, 4, 2013. Crossref

  6. Frau Maddalena, Feo Francesco, Pascale Rosa M., Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis, Journal of Hepatology, 59, 4, 2013. Crossref

  7. Calvisi Diego F., Simile Maria M., Ladu Sara, Pellegrino Rossella, De Murtas Valentina, Pinna Federico, Tomasi Maria L., Frau Maddalena, Virdis Patrizia, De Miglio Maria R., Muroni Maria R., Pascale Rosa M., Feo Francesco, Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis, International Journal of Cancer, 121, 11, 2007. Crossref

  8. Pascale Rosa M., Simile Maria M., Calvisi Diego F., Frau Maddalena, Muroni Maria R., Seddaiu Maria A., Daino Lucia, Muntoni Maria D., De Miglio Maria R., Thorgeirsson Snorri S., Feo Francesco, Role of HSP90, CDC37, and CRM1 as modulators of P16INK4Aactivity in rat liver carcinogenesis and human liver cancer, Hepatology, 42, 6, 2005. Crossref

  9. Klein Patrick J., Schmidt C. Max, Wiesenauer Chad A., Choi Jennifer N., Gage Earl A., Yip-Schneider Michele T., Wiebke Eric A., Wang Yufang, Omer Charles, Sebolt-Leopold Judith S., The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer, Neoplasia, 8, 1, 2006. Crossref

  10. Calvisi Diego F., Pinna Federico, Ladu Sara, Pellegrino Rossella, Muroni Maria R., Simile Maria M., Frau Maddalena, Tomasi Maria L., De Miglio Maria R., Seddaiu Maria A., Daino Lucia, Sanna Valeria, Feo Francesco, Pascale Rosa M., Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease, Carcinogenesis, 29, 8, 2008. Crossref

  11. Bin-Meferi Mashael Mohammed, Histological and Immunohistochemical Studies for Evaluation of the Role of Microalgae Spirulina sp. Against Cancer in Experimental Animals, International Journal of Cancer Research, 5, 1, 2008. Crossref

  12. Nakae Dai, Uematsu Fumiyuki, Kishida Hideki, Kusuoka Osamu, Katsuda Shin-ichi, Yoshida Midori, Takahashi Masakazu, Maekawa Akihiko, Denda Ayumi, Konishi Yoichi, Kotake Yashige, Floyd Robert A, Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, l-amino acid-defined diet, Cancer Letters, 206, 1, 2004. Crossref

  13. Pascale Rosa M., Simile Maria M., De Miglio Maria R., Feo Francesco, Chemoprevention of hepatocarcinogenesis, Alcohol, 27, 3, 2002. Crossref

  14. Naito A., Roberts R., Dragan Y., Nongenotoxic Carcinogenesis, in Comprehensive Toxicology, 2010. Crossref

  15. Hussain Talib, Siddiqui Hefazat H, Fareed Sheeba, Vijayakumar Madhavan, Rao Chandana Venkateswara, Chemopreventive evaluation of Tephrosia purpurea against N-nitrosodiethylamine-induced hepatocarcinogenesis in Wistar rats, Journal of Pharmacy and Pharmacology, 64, 8, 2012. Crossref

  16. Sivaramakrishnan Venkatabalasubramanian, Shilpa Perumal Narasimha Moorthy, Praveen Kumar Varuvoor Rajesh, Niranjali Devaraj Sivasitambaram, Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol—Morin, Chemico-Biological Interactions, 171, 1, 2008. Crossref

  17. Wiesenauer Chad A, Yip-Schneider Michele T, Wang Yufang, Schmidt Max C., Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma1, Journal of the American College of Surgeons, 198, 3, 2004. Crossref

  18. Ghosh Debasree, Choudhury Somsubhra Thakur, Ghosh Swarupa, Mandal Ardhendu K., Sarkar Sibani, Ghosh Aparajita, Saha Krishna Das, Das Nirmalendu, Nanocapsulated curcumin: Oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat, Chemico-Biological Interactions, 195, 3, 2012. Crossref

  19. Calvisi Diego F., Frau Maddalena, Tomasi Maria L., Feo Francesco, Pascale Rosa M., Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1826, 1, 2012. Crossref

  20. Calvisi Diego F., Ladu Sara, Gorden Alexis, Farina Miriam, Conner Elizabeth A., Lee Ju–Seog, Factor Valentina M., Thorgeirsson Snorri S., Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC, Gastroenterology, 130, 4, 2006. Crossref

  21. Lotz Gábor, Kiss András, Novák Pál Kaposi, Sobel Gábor, Schaff Zsuzsa, Hepatitis viruses and hepatocarcinogenesis, Journal of Physiology-Paris, 95, 1-6, 2001. Crossref

  22. Simile M. M., De Miglio M. R., Calvisi D., Muroni M. R., Frau M., Asara G., Daino L., Deiana L., Pascale R. M., Feo F., Long-term dehydroepiandrosterone and 16 -fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats, Carcinogenesis, 22, 2, 2001. Crossref

  23. Hennig Matthew, Yip-Schneider Michele T., Klein Patrick, Wentz Sabrina, Matos Jesus M., Doyle Courtney, Choi Jennifer, Wu Huangbing, O'Mara Amanda, Menze Alex, Noble Stephen, McKillop Iain H., Schmidt C. Max, Ethanol-TGFα-MEK Signaling Promotes Growth of Human Hepatocellular Carcinoma, Journal of Surgical Research, 154, 2, 2009. Crossref

  24. Pascale Rosa M., Joseph Christy, Latte Gavinella, Evert Matthias, Feo Francesco, Calvisi Diego F., DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?, DNA Repair, 47, 2016. Crossref

  25. Qi Shibo, Li Bin, Yang Tan, Liu Yong, Cao Shanshan, He Xingxing, Zhang Peng, Li Lei, Xu Chuanrui, Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice, International Journal of Molecular Sciences, 15, 11, 2014. Crossref

  26. Feo Francesco, Frau Maddalena, Pascale Rosa Maria, Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis, World Journal of Gastroenterology, 14, 43, 2008. Crossref

  27. Naito A., Roberts R., Dragan Y., Nongenotoxic Carcinogenesis, in Reference Module in Biomedical Sciences, 2017. Crossref

  28. Bursch Wilfried, Genotoxic, Non-Genotoxic and Epigenetic Mechanisms in Chemical Hepatocarcinogenesis, in Epigenetics and Human Health, 2010. Crossref

  29. Naito A., Roberts R., Dragan Y., Nongenotoxic Carcinogenesis, in Comprehensive Toxicology, 2018. Crossref

  30. Tischoff Iris, DNA methylation in hepatocellular carcinoma, World Journal of Gastroenterology, 14, 11, 2008. Crossref

  31. Dakshayani K.B., Subramanian P., α-Ketoglutarate Modulates the Circadian Patterns of Lipid Peroxidation and Antioxidant Status During N-Nitrosodiethylamine-Induced Hepatocarcinogenesis in Rats, Journal of Medicinal Food, 9, 1, 2006. Crossref

  32. Gross-Goupil Marine, Riou Philippe, Emile Jean-Fran�ois, Saffroy Rapha�l, Azoulay Daniel, Lacherade Isabelle, Receveur Aline, Piatier-Tonneau Dominique, Castaing Denis, Debuire Brigitte, Lemoine Antoinette, Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation, International Journal of Cancer, 104, 6, 2003. Crossref

  33. Pascale Rosa M., Simile Maria M., De Miglio Maria R., Muroni Maria R., Calvisi Diego F., Asara Giuseppina, Casabona Daniela, Frau Maddalena, Seddaiu Maria A., Feo Francesco, Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis, Hepatology, 35, 6, 2002. Crossref

  34. Xu An, Wang Bibo, Fu Jing, Qin Wenhao, Yu Ting, Yang Zhishi, Lu Qingjun, Chen Jingyi, Chen Yao, Wang Hongyang, Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α, Cancer Letters, 442, 2019. Crossref

  35. Lim In Kyoung, Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats, Mechanisms of Ageing and Development, 123, 12, 2002. Crossref

  36. Wu Lijun, Chen Ping, Ying Jun, Zhang Qi, Liu Fuchen, Lv Bin, Che Zhihui, Zhang Wenli, Wu Mengmeng, Zhang Jun, Yang Dongqin, Liu Jie, MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma, Clinical and Experimental Medicine, 19, 4, 2019. Crossref

  37. Pascale Rosa M., Simile Maria M., Peitta Graziella, Seddaiu Maria A., Feo Francesco, Calvisi Diego F., Experimental Models to Define the Genetic Predisposition to Liver Cancer, Cancers, 11, 10, 2019. Crossref

  38. Lim In Kyoung, Erratum to “Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats” [Mechanisms of Ageing and Development 123 (2002) 1665–1680], Mechanisms of Ageing and Development, 124, 5, 2003. Crossref

  39. Simile Maria M., Peitta Graziella, Tomasi Maria L., Brozzetti Stefania, Feo Claudio F., Porcu Alberto, Cigliano Antonio, Calvisi Diego F., Feo Francesco, Pascale Rosa M., MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes, Oncotarget, 10, 29, 2019. Crossref

  40. Fu Xiaowei, Zhu Yaqiong, Zheng Bingbing, Zou Yeqing, Wang Chao, Wu Peng, Wang Jun, Chen Haimin, Du Pengcheng, Liang Bo, Fang Lu, KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma, International Journal of Oncology, 2018. Crossref

  41. Abdel-Hamid Nabil Mohie, Abd Allah Sara Gamal, Hassan Mohamed K., Ahmed Amal A.M., Anber Nahla H., Adel Faried Ibrahim, Possible Protective Potency of Argun Nut (Medemia argun – An Ancient Egyptian Palm) against Hepatocellular Carcinoma in Rats, Nutrition and Cancer, 74, 2, 2022. Crossref

  42. Kempinska Katarzyna, Malik Bhavna, Borkin Dmitry, Klossowski Szymon, Shukla Shirish, Miao Hongzhi, Wang Jingya, Cierpicki Tomasz, Grembecka Jolanta, Pharmacologic Inhibition of the Menin–MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma, Molecular Cancer Therapeutics, 17, 1, 2018. Crossref

  43. Delpuech Oona, Trabut Jean-Baptiste, Carnot Françoise, Feuillard Jean, Brechot Christian, Kremsdorf Dina, Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma, Oncogene, 21, 18, 2002. Crossref

  44. Yakicier M Cengiz, Legoix Patricia, Vaury Christelle, Gressin Laetitia, Tubacher Emmanuel, Capron Frédérique, Bayer Jan, Degott Claude, Balabaud Charles, Zucman-rossi Jessica, Identification of homozygous deletions at chromosome 16q23 in Aflatoxin B1 exposed hepatocellular carcinoma, Oncogene, 20, 37, 2001. Crossref

  45. Newell Philippa, Villanueva Augusto, Friedman Scott L., Koike Kazuhiko, Llovet Josep M., Experimental models of hepatocellular carcinoma, Journal of Hepatology, 48, 5, 2008. Crossref

  46. Pascale Rosa M., Calvisi Diego F., Feo Francesco, Simile Maria M., Genetic Predisposition to Hepatocellular Carcinoma, Metabolites, 13, 1, 2022. Crossref

  47. Zhang Zhan, Wang Di, Qiao Shanlei, Wu Xinyue, Cao Shuyuan, Wang Li, Su Xiaojian, Li Lei, Metabolic and microbial signatures in rat hepatocellular carcinoma treated with caffeic acid and chlorogenic acid, Scientific Reports, 7, 1, 2017. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain